Keybank National Association OH lessened its holdings in Chemed Corporation (NYSE:CHE – Free Report) by 93.6% in the third quarter, according to its most recent filing with the SEC. The institutional investor owned 614 shares of the company’s stock after selling 8,910 shares during the period. Keybank National Association OH’s holdings in Chemed were worth $275,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also bought and sold shares of CHE. Norges Bank bought a new position in shares of Chemed in the second quarter worth about $89,388,000. AQR Capital Management LLC boosted its stake in Chemed by 160.9% in the 2nd quarter. AQR Capital Management LLC now owns 201,041 shares of the company’s stock worth $97,893,000 after purchasing an additional 123,982 shares during the period. Acadian Asset Management LLC boosted its stake in Chemed by 69.3% in the 2nd quarter. Acadian Asset Management LLC now owns 250,722 shares of the company’s stock worth $122,056,000 after purchasing an additional 102,597 shares during the period. Allspring Global Investments Holdings LLC grew its holdings in Chemed by 188.7% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 83,704 shares of the company’s stock valued at $36,883,000 after buying an additional 54,713 shares in the last quarter. Finally, Schroder Investment Management Group raised its position in shares of Chemed by 88.1% during the second quarter. Schroder Investment Management Group now owns 86,625 shares of the company’s stock valued at $42,180,000 after buying an additional 40,571 shares during the last quarter. 95.85% of the stock is owned by institutional investors.
Chemed Stock Down 1.3%
NYSE CHE opened at $447.56 on Friday. Chemed Corporation has a 52 week low of $408.42 and a 52 week high of $623.60. The firm has a market capitalization of $6.34 billion, a price-to-earnings ratio of 23.67, a PEG ratio of 2.18 and a beta of 0.44. The company has a fifty day moving average of $436.81 and a two-hundred day moving average of $441.97.
Insider Activity at Chemed
Wall Street Analyst Weigh In
A number of equities analysts recently weighed in on the stock. Royal Bank Of Canada dropped their target price on shares of Chemed from $589.00 to $572.00 and set an “outperform” rating for the company in a research report on Monday, November 10th. Zacks Research raised shares of Chemed from a “strong sell” rating to a “hold” rating in a report on Thursday, October 30th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Chemed in a report on Wednesday, January 21st. Finally, Jefferies Financial Group downgraded Chemed from a “buy” rating to a “hold” rating in a research report on Thursday, January 22nd. Three equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $555.50.
Get Our Latest Report on Chemed
About Chemed
Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.
The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.
Read More
- Five stocks we like better than Chemed
- NEW LAW: Congress Approves Setup For Digital Dollar?
- The $650 Million Bet on AI’s Future
- The gold chart Wall Street is terrified of…
- The buying spree that no one is talking about
- Trump’s AI Secret: 100X Faster Than Nvidia
Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Corporation (NYSE:CHE – Free Report).
Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.
